The anti-inflammatory effects of fasting, evidenced by reductions in hs-CRP levels, are of particular relevance in the context of T2DM, as chronic low-grade inflammation is implicated in the pathogenesis of insulin resistance and metabolic dysfunction (21). This evidence concerns the gene MAP3K14 and type 2 diabetes mellitus.